Vaxcyte Q1 EPS $(1.04) Beats $(1.11) Estimate

Benzinga · 5d ago
Vaxcyte (NASDAQ:PCVX) reported quarterly losses of $(1.04) per share which beat the analyst consensus estimate of $(1.11) by 6.31 percent. This is a 22.35 percent decrease over losses of $(0.85) per share from the same period last year.